The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Treatments for asthma include reliever inhalers ... One additional measurement is a six-minute walking test. Early on in pulmonary rehab, you'll walk as far as you can in six minutes to see ...

A breakthrough study shows an injection could be more effective than current standard care of steroid tablets, showing it cut ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...